Learning Objectives:

  1. Understand the continuum of risk in ASCVD.

 

  1. Understand how to identify high risk primary prevention patients in clinical practice and utilize recent data from clinical trials to manage these patients.  

 

  1. Understand how to apply the AHA CKM framework to clinical practice.
Session date: 
05/03/2024 - 12:00pm to 1:00pm CDT
Location: 
Zoom
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Pam Taub, MD